RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 108 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 4.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $50,000 | +257.1% | 42,212 | +833.1% | 0.00% | – |
| Q1 2022 | $14,000 | -22.2% | 4,524 | -34.1% | 0.00% | -100.0% |
| Q4 2021 | $18,000 | -37.9% | 6,868 | -14.6% | 0.00% | 0.0% |
| Q3 2021 | $29,000 | +480.0% | 8,039 | +491.1% | 0.00% | – |
| Q1 2021 | $5,000 | -58.3% | 1,360 | -61.2% | 0.00% | -100.0% |
| Q4 2020 | $12,000 | +71.4% | 3,501 | +26.0% | 0.00% | 0.0% |
| Q3 2020 | $7,000 | +75.0% | 2,779 | +31.3% | 0.00% | 0.0% |
| Q3 2019 | $4,000 | +300.0% | 2,117 | +617.6% | 0.00% | – |
| Q2 2018 | $1,000 | -96.2% | 295 | -95.9% | 0.00% | -100.0% |
| Q3 2016 | $26,000 | – | 7,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |